Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination


Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site. (US Food Recalls) More More

Similar stories

Novartis issues voluntary nationwide recall of Promacta 12.5 mg for oral suspension due to potential peanut contamination - New Kerala

Novartis issues voluntary nationwide recall of Promacta 12.5 mg for oral suspension due to potential peanut contamination  New Kerala

EAST HANOVER, N.J: Novartis announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral ...

Posted on 1 June 2019 | 2:00 am | Google News

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination - Pharmacy Times

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination  Pharmacy Times

Novartis has issued a voluntary recall of 3 lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level, due to a risk of potential peanut ...

Posted on 13 May 2019 | 2:00 am | Google News

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination - FDA.gov

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination  FDA.gov

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...

Posted on 12 May 2019 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info